Table 3 Cardiovascular risk scores assessed in 1997-1999 for males (n = 2 411) and females (n = 2 448) using cardiovascular medication (CVM) in 2008 versus those not on CVM (males: n = 6 872, females: n = 8 521)1.
Males | Females | |||||
|---|---|---|---|---|---|---|
Risk score algorithm | CVM | No CVM | 95% CI for difference | CVM | No CVM | 95% CI for difference |
Framingham | 13.1 | 8.8* | 3.9,4.5 | 5.7 | 3.2* | 2.3,2.6 |
Framingham at 60 y | 25.6 | 19.1* | 6.0,6.9 | 12.7 | 8.1* | 4.2,4.8 |
SCORE | 1.8 | 1.2* | 0.59,0.76 | 0.2 | 0.1* | 0.09,0.10 |
SCORE at 60y | 8.2 | 5.7* | 2.3,2.7 | 2.1 | 1.4* | 0.69,0.78 |
NORRISK | 1.20 | 0.78* | 0.36,0.47 | 0.32 | 0.20* | 0.11,0.13 |